2017 Fiscal Year Final Research Report
Development of sophisticated small RNAs utilizing the properties of functional groups
| Project/Area Number |
16K18911
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Drug development chemistry
|
|---|
| Research Institution | Gifu University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
KITADE YUKIO 愛知工業大学, 工学部, 教授 (20137061)
IKEDA MASATO 岐阜大学, 工学部, 教授 (20432867)
AYA SHIBATA 岐阜大学, 工学部, 助教 (50462693)
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Keywords | 核酸医薬 / 機能性短鎖RNA / 環境応答 / 分解酵素耐性 / 簡便合成 / CuAAC |
|---|
| Outline of Final Research Achievements |
Small interfering RNAs (siRNAs) and microRNAs inhibit gene expression by RNA interference (RNAi) and thus have great potential as nucleic acid-based drugs. However, naked RNA strands have many problems that hinder their application as therapeutics, such as their rapid degradation in biological fluids, poor cellular uptake, and off-target effects. In the course of our study, we focused on studying siRNAs containing nucleoside mimics in their 3'-termini. In this study, we found that furanoid glycals could be useful as stimulus-responsive units. In addition, it was found that introduction of 2-O-benzylated abasic nucleoside (RHOBn) at the 3'-end of an siRNA greatly improves resistance towards various nucleases. Furthermore, we have developed a scalable synthetic method for phosphoramidite derivatives of artificial nucleosides including 1-deoxy-1-ethynyl-β-D-ribofuranose (RE). These results should help to advance the development of RNAi-based medicine.
|
| Free Research Field |
医歯薬学
|
